Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.69 |
| ▸ | GRM8 | O00222 | 2/20 | 0.69 |
| ▸ | GRM6 | O15303 | 2/20 | 0.69 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.69 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.69 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.69 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.69 |
| ▸ | GSR | P00390 | 1/20 | 0.69 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.69 |
| ▸ | GRM5 | P41594 | 1/20 | 0.69 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.69 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.69 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.69 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.69 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.69 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.69 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.69 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.69 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.69 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glutamic Acid SCHEMBL1527702 | 1.00 | CYP1A2 (0.69) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Glutamic Acid SCHEMBL2501322 | 1.00 | CYP1A2 (0.69) | CYP1A2GRM8GRM6GRM7GRM4 | |
| D-Glutamate SCHEMBL25337565 | 0.95 | CYP1A2 (0.62) | CYP1A2GRM8GRM6GRM7GRM4 | |
| D-Glutamate SCHEMBL27287949 | 0.93 | CYP1A2 (0.60) | CYP1A2GRM8GRM6GRM7GRM4 | |
| D-Glutamate SCHEMBL27691480 | 0.93 | CYP1A2 (0.60) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Glutamic Acid SCHEMBL6130151 | 0.92 | SLC1A3 (0.58) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Glutamic Acid SCHEMBL9716073 | 0.90 | CYP1A2 (0.56) | CYP1A2GRM8GRM6GRM7GRM4 | |
| Glutamic Acid SCHEMBL9716085 | 0.90 | CYP1A2 (0.56) | CYP1A2GRM8GRM6GRM7GRM4 | |
| D-Glutamate SCHEMBL23777456 | 0.87 | SLC1A3 (0.53) | CYP1A2GRM8GRM6GRM7GRM4 | |
| D-Glutamate SCHEMBL27591999 | 0.87 | CYP1A2 (0.53) | CYP1A2GRM8GRM6GRM7GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011053167-A1 | TRANSCRIPTION FACTOR POLYNUCLEOTIDES AND THEIR USE | GRASSLANZ TECHNOLOGY LIMITED (NZ) | 2011-05-05 | — | — | WO | claimed |
| CN-101134948-A | S-adenosine methilanin synthase mutant, DNA encoding the mutant and application of the mutant | BIORIGHT WORLDWIDE CO LTD (VG) | 2008-03-05 | — | — | CN | claimed |
| US-20210107977-A1 | METHODS AND COMPOSITIONS FOR TREATING FIBROTIC DISEASES | ALLAKOS INC (US) | 2021-04-15 | — | — | US | disclosed |
| CN-110325546-A | DNA MONOCLONAL ANTIBODIES TARGETING INFLUENZA VIRUS | 宾夕法尼亚大学理事会 | 2019-10-11 | — | — | CN | disclosed |
| CN-110167584-A | DNA antibody constructs for targeting lyme disease | 威斯塔解剖学和生物学研究所 | 2019-08-23 | — | — | CN | disclosed |
| CN-110072554-A | DNA antibody construct for resisting pseudomonas aeruginosa | 宾夕法尼亚大学理事会 | 2019-07-30 | — | — | CN | disclosed |
| CN-109789225-A | DNA MONOCLONAL ANTIBODIES TARGETING CHECKPOINT MOLECULES | 宾夕法尼亚大学理事会 | 2019-05-21 | — | — | CN | disclosed |
| CN-109789224-A | DNA MONOCLONAL ANTIBODIES TARGETING IL-6 AND CD126 | 宾夕法尼亚大学理事会 | 2019-05-21 | — | — | CN | disclosed |
| US-8900849-B2 | Oxygen-regulated microorganisms | SCARAB GENOMICS, LLC (US) | 2014-12-02 | — | — | US | disclosed |
| US-8354372-B2 | Cyclised alpha-conotoxin peptides | THE UNIVERSITY OF QUEENSLAND (AU) | 2013-01-15 | — | — | US | disclosed |
| WO-2011053167-A1 | TRANSCRIPTION FACTOR POLYNUCLEOTIDES AND THEIR USE | GRASSLANZ TECHNOLOGY LIMITED (NZ) | 2011-05-05 | — | — | WO | disclosed |
| US-20090053792-A1 | OXYGEN-REGULATED MICROORGANISMS | SCARAB GENOMICS, LLC (US) | 2009-02-26 | — | — | US | disclosed |
| CN-85101907-A | The manufacturing of single segment dominent human r gamma-interferon | — | 1987-01-10 | — | — | CN | disclosed |